tiprankstipranks
Advertisement
Advertisement

MIRA Stock Latest News

MIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial
Company AnnouncementsMIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial
15h ago
8K
MIRA
Mira Pharmaceuticals submits Phase 2a trial protocol to U.S. FDA for Ketamir-2
PremiumThe Fly
Mira Pharmaceuticals submits Phase 2a trial protocol to U.S. FDA for Ketamir-2
15h ago
MIRA
Psychedelic: Optimi Health completes psilocybin export to the UK
PremiumThe Fly
Psychedelic: Optimi Health completes psilocybin export to the UK
7d ago
IXHL
MIRA
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
PremiumCompany Announcements
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
9d ago
8K
MIRA
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
PremiumThe Fly
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
14d ago
CMND
ENVB
MIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
PremiumCompany AnnouncementsMIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
14d ago
8K
MIRA
Mira Pharmaceuticals secures worldwide rights to MIRA-55, SKNY-1
Premium
The Fly
Mira Pharmaceuticals secures worldwide rights to MIRA-55, SKNY-1
14d ago
MIRA
Psychedelic: Optimi Health advances natural psilocybin extract
Premium
The Fly
Psychedelic: Optimi Health advances natural psilocybin extract
20d ago
CMND
CMPS
Mira Pharmaceuticals secures worldwide rights for Ketamir-2
PremiumThe Fly
Mira Pharmaceuticals secures worldwide rights for Ketamir-2
22d ago
MIRA
MIRA Expands Global Ketamir-2 License for Clinical Development
PremiumCompany Announcements
MIRA Expands Global Ketamir-2 License for Clinical Development
22d ago
8K
MIRA
Mira Pharmaceuticals management to meet with Maxim
PremiumThe Fly
Mira Pharmaceuticals management to meet with Maxim
22d ago
MIRA
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
PremiumThe Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
1M ago
ATAI
CMND
Mira announces results from Phase 1 trial evaluating Ketamir-2
PremiumThe FlyMira announces results from Phase 1 trial evaluating Ketamir-2
1M ago
MIRA
MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results
Premium
Company Announcements
MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results
1M ago
8K
MIRA
Mira announces acceptance of peer-reviewed SKNY-1 manuscript
Premium
The Fly
Mira announces acceptance of peer-reviewed SKNY-1 manuscript
1M ago
MIRA
MIRA highlights SKNY-1 preclinical data in new publication
PremiumCompany Announcements
MIRA highlights SKNY-1 preclinical data in new publication
1M ago
8K
MIRA
MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55
PremiumCompany Announcements
MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55
3M ago
8K
MIRA
Mira reports Mira-55 shows no THC-, Rimonabant-associated CNS side effects
PremiumThe Fly
Mira reports Mira-55 shows no THC-, Rimonabant-associated CNS side effects
3M ago
MIRA
Mira Pharmaceuticals completes Phase 1 dosing of Ketamir-2
PremiumThe Fly
Mira Pharmaceuticals completes Phase 1 dosing of Ketamir-2
4M ago
MIRA
MIRA Completes Phase 1 Trial of Ketamir-2 Therapy
PremiumCompany AnnouncementsMIRA Completes Phase 1 Trial of Ketamir-2 Therapy
4M ago
8K
MIRA
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
Premium
The Fly
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
4M ago
CMND
DFTX
Mira Pharmaceuticals initiates final cohort of Ketamir-2 Phase 1 study
Premium
The Fly
Mira Pharmaceuticals initiates final cohort of Ketamir-2 Phase 1 study
4M ago
MIRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >